Mga Batayang Estadistika
| CIK | 17485 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Liberator Medical Holdings, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 1, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 1)* Under the Securities Exchange Act of 1934 LIBERATOR MEDICAL HOLDINGS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 53012L108 (CUSIP Number) Mark A. Libratore c/o Liberator Medical Holdings, Inc. 2979 SE Gran Park Way Stuart, Florida 34997 (772) 287-2414 wit |
|
| February 1, 2016 |
Liberator Medical Holdings 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-05663 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as spe |
|
| January 26, 2016 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Final Amendment) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 84 |
|
| January 22, 2016 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The NYSE MKT LLC hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on February 2, 2016, pursuant to the provisions of Rule 12d2-2 (a). |
|
| January 21, 2016 |
Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 21, 2016 |
Schedule 13D Amendment NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, $0.001 par value 53012L108 (Title of class of securities) (CUSIP number) Samrat S. Khichi, Esq. Senior Vice President, General Counsel and Secretary C. R. Bard, |
|
| January 21, 2016 |
Liberator Medical Holdings Form S-8 POS Post-Effective Amendment No.1 to Form S-8 As filed with the Securities and Exchange Commission on January 21, 2016 Registration Statement No. 333-159883 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-159883 UNDER THE SECURITIES ACT OF 1933 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as |
|
| January 21, 2016 |
CERTIFICATE OF AMENDED AND RESTATED ARTICLES OF INCORPORATION LIBERATOR MEDICAL HOLDINGS, INC. EX-3.1 2 f8k012116ex3z1.htm EXHIBIT 3.1 AMENDED AND RESTATED ARTICLES OF INCORPORATION CERTIFICATE OF AMENDED AND RESTATED ARTICLES OF INCORPORATION OF LIBERATOR MEDICAL HOLDINGS, INC. Pursuant to the provisions of Nevada Revised Statutes 78.390 and 78.403, the undersigned officer of Liberator Medical Holdings, Inc., a Nevada corporation, does hereby certify as follows: A. The Agreement and Plan o |
|
| January 21, 2016 |
Liberator Medical Holdings Form 8-K (Current Report/Significant Event) Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 21, 2016 |
AMENDED AND RESTATED BY-LAWS LIBERATOR MEDICAL HOLDINGS, INC. EX-3.2 3 f8k012116ex3z2.htm EXHIBIT 3.2 AMENDED AND RESTATED BY-LAWS AMENDED AND RESTATED BY-LAWS OF LIBERATOR MEDICAL HOLDINGS, INC. Section 1. ARTICLES OF INCORPORATION AND BY-LAWS 1.1 These By-Laws are subject to the Articles of Incorporation of the corporation. In these By-Laws, references to the Articles of Incorporation and By-Laws mean the provisions of the Articles of Incorporation and the |
|
| January 21, 2016 |
AMENDED AND RESTATED BY-LAWS LIBERATOR MEDICAL HOLDINGS, INC. EX-3.2 3 f8k012116ex3z2.htm EXHIBIT 3.2 AMENDED AND RESTATED BY-LAWS AMENDED AND RESTATED BY-LAWS OF LIBERATOR MEDICAL HOLDINGS, INC. Section 1. ARTICLES OF INCORPORATION AND BY-LAWS 1.1 These By-Laws are subject to the Articles of Incorporation of the corporation. In these By-Laws, references to the Articles of Incorporation and By-Laws mean the provisions of the Articles of Incorporation and the |
|
| January 21, 2016 |
CERTIFICATE OF AMENDED AND RESTATED ARTICLES OF INCORPORATION LIBERATOR MEDICAL HOLDINGS, INC. Exhibit 3.1 Amended and Restated Articles of Incorporation CERTIFICATE OF AMENDED AND RESTATED ARTICLES OF INCORPORATION OF LIBERATOR MEDICAL HOLDINGS, INC. Pursuant to the provisions of Nevada Revised Statutes 78.390 and 78.403, the undersigned officer of Liberator Medical Holdings, Inc., a Nevada corporation, does hereby certify as follows: A. The Agreement and Plan of Merger, dated as of Novemb |
|
| January 21, 2016 |
Liberator Medical Holdings POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 Post-Effective Amendment No.1 to Form S-8 As filed with the Securities and Exchange Commission on January 21, 2016 Registration Statement No. 333-159883 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-159883 UNDER THE SECURITIES ACT OF 1933 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as |
|
| January 7, 2016 |
EX-99.1 2 f8k010716ex99z1.htm EXHIBIT 99.1 PRESS RELEASE EXHIBIT 99.1 ISS and Glass Lewis Recommend that Liberator Medical Shareholders Vote “FOR” Merger Agreement with C. R. Bard, Inc. STUART, Fla., January 7, 2016 (MARKETWIRED) - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) (“Liberator”) announced today that two leading proxy-advisory firms have recommended that Liberator’s shareholders vot |
|
| January 7, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2016 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 001-36186 87-0267292 (State or other jurisdiction of incorporation) (Com |
|
| January 7, 2016 |
Liberator Medical Holdings DEFINITIVE ADDITIONAL MATERIALS Definitive Additional Materials UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 7, 2016 |
Liberator Medical Holdings Form 8-K (Current Report/Significant Event) FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 7, 2016 |
EX-99.1 2 f8k010716ex99z1.htm EXHIBIT 99.1 PRESS RELEASE EXHIBIT 99.1 ISS and Glass Lewis Recommend that Liberator Medical Shareholders Vote “FOR” Merger Agreement with C. R. Bard, Inc. STUART, Fla., January 7, 2016 (MARKETWIRED) - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) (“Liberator”) announced today that two leading proxy-advisory firms have recommended that Liberator’s shareholders vot |
|
| December 29, 2015 |
Liberator Medical Holdings DEFM14A DEFM14A 1 d99034ddefm14a.htm DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| December 23, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 f8k1222158k.htm FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2015 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 001-36186 87-0267292 (St |
|
| December 23, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 23, 2015 |
Exhibit 99.2 Settlement Agreement SETTLEMENT AGREEMENT This Settlement Agreement (Agreement) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS), Liberator Medical Supply, Inc. (?Liberator?), and relators Kimberly Herman, Amy Lestage |
|
| December 23, 2015 |
Liberator Medical Announces Definitive Settlement of Qui Tam Litigation Exhibit 99.1 Press Release Liberator Medical Announces Definitive Settlement of Qui Tam Litigation STUART, FL (Marketwired) - 12/22/15 - Liberator Medical Holdings, Inc. (?Liberator?) (NYSE MKT: LBMH), a leading national direct-to-consumer provider of quality medical supplies through its subsidiary, Liberator Medical Supply, Inc., today announced that it has entered into a definitive settlement wi |
|
| December 23, 2015 |
EX-99.2 3 f8k122215ex99z2.htm EXHIBIT 99.2 SETTLEMENT AGREEMENT SETTLEMENT AGREEMENT This Settlement Agreement (Agreement) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS), Liberator Medical Supply, Inc. (“Liberator”), and relator |
|
| December 23, 2015 |
Liberator Medical Announces Definitive Settlement of Qui Tam Litigation EX-99.1 2 f8k122215ex99z1.htm EXHIBIT 99.1 PRESS RELEASE Liberator Medical Announces Definitive Settlement of Qui Tam Litigation STUART, FL (Marketwired) - 12/22/15 - Liberator Medical Holdings, Inc. (“Liberator”) (NYSE MKT: LBMH), a leading national direct-to-consumer provider of quality medical supplies through its subsidiary, Liberator Medical Supply, Inc., today announced that it has entered i |
|
| December 15, 2015 |
Liberator Medical Holdings FORM 8-K CURRENT REPORT FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 15, 2015 |
Exhibit 99.1 Press Release Liberator Medical Reports Revenue of $81.6 Million for its Fiscal Year Ended September 30, 2015, Declares Cash Dividend of Up to $0.0325 per Share December 14, 2015 18:29 ET The Company Reports Net Income of $7.3 Million, or $0.14 per share, for the Year STUART, Fla., December 14, 2015 (MARKETWIRED) - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) (the ?Company?) toda |
|
| December 15, 2015 |
Exhibit 99.1 Press Release Liberator Medical Reports Revenue of $81.6 Million for its Fiscal Year Ended September 30, 2015, Declares Cash Dividend of Up to $0.0325 per Share December 14, 2015 18:29 ET The Company Reports Net Income of $7.3 Million, or $0.14 per share, for the Year STUART, Fla., December 14, 2015 (MARKETWIRED) - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) (the ?Company?) toda |
|
| December 15, 2015 |
Liberator Medical Holdings Form 8-K (Current Report/Significant Event) FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 15, 2015 |
EX-99.1 2 f8k121415ex99z1.htm EXHIBIT 99.1 PRESS RELEASE Liberator Medical Reports Revenue of $81.6 Million for its Fiscal Year Ended September 30, 2015, Declares Cash Dividend of Up to $0.0325 per Share December 14, 2015 18:29 ET The Company Reports Net Income of $7.3 Million, or $0.14 per share, for the Year STUART, Fla., December 14, 2015 (MARKETWIRED) - Liberator Medical Holdings, Inc. (NYSE M |
|
| December 15, 2015 |
Results of Operations and Financial Condition 8-K 1 f8k1214158k.htm FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2015 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 001-36186 87-0267292 (St |
|
| December 15, 2015 |
Exhibit 99.1 Press Release Liberator Medical Reports Revenue of $81.6 Million for its Fiscal Year Ended September 30, 2015, Declares Cash Dividend of Up to $0.0325 per Share December 14, 2015 18:29 ET The Company Reports Net Income of $7.3 Million, or $0.14 per share, for the Year STUART, Fla., December 14, 2015 (MARKETWIRED) - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) (the ?Company?) toda |
|
| December 14, 2015 |
Liberator Medical Holdings Form 10-K (Annual Report) Form 10-K Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 14, 2015 |
Exhibit 21.1 Subsidiaries SUBSIDIARIES OF LIBERATOR MEDICAL HOLDINGS, INC. Name of Subsidiary Jurisdiction of Organization Liberator Medical Supply, Inc. Florida Liberator Health and Education Services, Inc. Florida Liberator Health and Wellness, Inc. Florida Practica Medical Manufacturing, Inc. Florida Tri-County Medical & Ostomy Supplies, Inc. Tennessee |
|
| December 14, 2015 |
Exhibit 21.1 Subsidiaries SUBSIDIARIES OF LIBERATOR MEDICAL HOLDINGS, INC. Name of Subsidiary Jurisdiction of Organization Liberator Medical Supply, Inc. Florida Liberator Health and Education Services, Inc. Florida Liberator Health and Wellness, Inc. Florida Practica Medical Manufacturing, Inc. Florida Tri-County Medical & Ostomy Supplies, Inc. Tennessee |
|
| December 14, 2015 |
Liberator Medical Holdings FORM 10-K ANNUAL REPORT (Annual Report) Form 10-K Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 14, 2015 |
LEASE EXTENSION AGREEMENT THIS AGREEMENT, made and entered into this day of December 2013, by and between SUNSHINE HOLDINGS, INC. |
|
| December 14, 2015 |
LEASE EXTENSION AGREEMENT THIS AGREEMENT, made and entered into this day of December 2013, by and between SUNSHINE HOLDINGS, INC. |
|
| December 14, 2015 |
Exhibit 10.06 Indemnification Agreement INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made as of August 19, 2010, by and between Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), and Jeannette Corbett (“Indemnitee”). WHEREAS, the Indemnitee is a director of the Company; WHEREAS, the Company and Indemnitee recognize the difficulty in obtaining direc |
|
| December 14, 2015 |
Exhibit 10.06 Indemnification Agreement INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made as of August 19, 2010, by and between Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), and Jeannette Corbett (“Indemnitee”). WHEREAS, the Indemnitee is a director of the Company; WHEREAS, the Company and Indemnitee recognize the difficulty in obtaining direc |
|
| December 14, 2015 |
LEASE EXTENSION AGREEMENT THIS AGREEMENT, made and entered into this day of December 2013, by and between SUNSHINE HOLDINGS, INC. |
|
| December 14, 2015 |
EX-10.07 3 f10k093015ex10z07.htm EXHIBIT 10.07 INDEMNIFICATION AGREEMENT INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made as of August 19, 2010, by and between Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), and Tyler Wick (“Indemnitee”). WHEREAS, the Indemnitee is a director of the Company; WHEREAS, the Company and Indemnitee recognize the dif |
|
| December 14, 2015 |
Exhibit 21.1 Subsidiaries SUBSIDIARIES OF LIBERATOR MEDICAL HOLDINGS, INC. Name of Subsidiary Jurisdiction of Organization Liberator Medical Supply, Inc. Florida Liberator Health and Education Services, Inc. Florida Liberator Health and Wellness, Inc. Florida Practica Medical Manufacturing, Inc. Florida Tri-County Medical & Ostomy Supplies, Inc. Tennessee |
|
| December 14, 2015 |
Exhibit 10.06 Indemnification Agreement INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made as of August 19, 2010, by and between Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), and Jeannette Corbett (“Indemnitee”). WHEREAS, the Indemnitee is a director of the Company; WHEREAS, the Company and Indemnitee recognize the difficulty in obtaining direc |
|
| December 14, 2015 |
Liberator Medical Holdings PREM14A PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 10, 2015 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 13) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 8 |
|
| December 4, 2015 |
LBMH / Liberator Medical Holdings, Inc. / LIBRATORE MARK A - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 LIBERATOR MEDICAL HOLDINGS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 53012L108 (CUSIP Number) Mark A. Libratore c/o Liberator Medical Holdings, Inc. 2979 SE Gran Park Way Stuart, Florida 34997 Telephone: (772) 287-2414 Copy |
|
| November 30, 2015 |
LBMH / Liberator Medical Holdings, Inc. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, $.001 (Title of Class of Securities) 53012L108 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Rece |
|
| November 25, 2015 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 12) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 8 |
|
| November 24, 2015 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 11) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 8 |
|
| November 24, 2015 |
LBMH / Liberator Medical Holdings, Inc. / BARD C R INC /NJ/ - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 LIBERATOR MEDICAL HOLDINGS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 53012L108 (CUSIP Number) Samrat S. Khichi, Esq. Senior Vice President, General Counsel and Secretary C. R. Bard, Inc. 730 Central Avenue Murray Hill |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
EX-2.1 2 d48841dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?Me |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this Agreement), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (Parent), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the Company), identified on Schedule A hereto (each, a Shareholder and, collectively, the Shareholders). |
|
| November 20, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2015 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 001-36186 87-0267292 (State or other jurisdiction (Commission (IRS |
|
| November 20, 2015 |
Liberator Medical Holdings Form 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2015 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 001-36186 87-0267292 (State or other jurisdiction (Commission (IRS |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this Agreement) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (Parent), Liberator Medical Holdings, Inc., a Nevada corporation (the Company), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (MergerSub), and John Lé |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 5 d48841dex102.htm EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owne |
|
| November 20, 2015 |
EX-2.1 2 d48841dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 5 d48841dex102.htm EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owne |
|
| November 20, 2015 |
EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this ?Agreement?), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), identified on Schedule A hereto (each, a ?Shareholder? and, collectively, the ?Sharehol |
|
| November 20, 2015 |
EX-2.2 3 d48841dex22.htm EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), identified on Schedule A hereto (each, a “Shareholder” and, co |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this Agreement), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (Parent), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the Company), identified on Schedule A hereto (each, a Shareholder and, collectively, the Shareholders). |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
EX-2.2 3 d48841dex22.htm EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), identified on Schedule A hereto (each, a “Shareholder” and, co |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?Me |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million EX-99.1 Exhibit 99.1 Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million STUART, FLORIDA?(MARKETWIRED)?November 20, 2015?Liberator Medical Holdings, Inc. (?Liberator?) (NYSEMKT: LBMH), a leading national direct-to-consumer provider of quality medical supplies through its subsidiary, Liberator Medical Supply, Inc., today announced that it has entered into a defini |
|
| November 20, 2015 |
Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million EX-99.1 7 d48841dex991.htm EX-99.1 Exhibit 99.1 Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million STUART, FLORIDA—(MARKETWIRED)—November 20, 2015—Liberator Medical Holdings, Inc. (“Liberator”) (NYSEMKT: LBMH), a leading national direct-to-consumer provider of quality medical supplies through its subsidiary, Liberator Medical Supply, Inc., today announced that i |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?Me |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
EX-2.2 3 d48841dex22.htm EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), identified on Schedule A hereto (each, a “Shareholder” and, co |
|
| November 20, 2015 |
EX-2.1 2 d48841dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers |
|
| November 20, 2015 |
Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this Agreement), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (Parent), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the Company), identified on Schedule A hereto (each, a Shareholder and, collectively, the Shareholders). |
|
| November 20, 2015 |
EX-2.1 2 d48841dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?Me |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 5 d48841dex102.htm EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owne |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
EX-2.2 3 d48841dex22.htm EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), identified on Schedule A hereto (each, a “Shareholder” and, co |
|
| November 20, 2015 |
EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers 2 1.6 Effect of the Merge |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 5 d48841dex102.htm EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owne |
|
| November 20, 2015 |
Liberator Medical Holdings 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2015 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 001-36186 87-0267292 (State or other jurisdiction (Commission (IRS |
|
| November 20, 2015 |
Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million EX-99.1 7 d48841dex991.htm EX-99.1 Exhibit 99.1 Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million STUART, FLORIDA—(MARKETWIRED)—November 20, 2015—Liberator Medical Holdings, Inc. (“Liberator”) (NYSEMKT: LBMH), a leading national direct-to-consumer provider of quality medical supplies through its subsidiary, Liberator Medical Supply, Inc., today announced that i |
|
| November 20, 2015 |
Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million EX-99.1 7 d48841dex991.htm EX-99.1 Exhibit 99.1 Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million STUART, FLORIDA—(MARKETWIRED)—November 20, 2015—Liberator Medical Holdings, Inc. (“Liberator”) (NYSEMKT: LBMH), a leading national direct-to-consumer provider of quality medical supplies through its subsidiary, Liberator Medical Supply, Inc., today announced that i |
|
| November 20, 2015 |
EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this ?Agreement?), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), identified on Schedule A hereto (each, a ?Shareholder? and, collectively, the ?Sharehol |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 5 d48841dex102.htm EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owne |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
EX-2.1 2 d48841dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?Me |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 5 d48841dex102.htm EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owne |
|
| November 20, 2015 |
Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this Agreement) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (Parent), Liberator Medical Holdings, Inc., a Nevada corporation (the Company), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (MergerSub), and John Lé |
|
| November 20, 2015 |
EX-2.1 2 d48841dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this ?Agreement?), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), identified on Schedule A hereto (each, a ?Shareholder? and, collectively, the ?Sharehol |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
EX-2.1 2 d48841dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers |
|
| November 20, 2015 |
Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this Agreement), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (Parent), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the Company), identified on Schedule A hereto (each, a Shareholder and, collectively, the Shareholders). |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this Agreement) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (Parent), Liberator Medical Holdings, Inc., a Nevada corporation (the Company), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (MergerSub), and John Lé |
|
| November 20, 2015 |
EX-2.2 3 d48841dex22.htm EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), identified on Schedule A hereto (each, a “Shareholder” and, co |
|
| November 20, 2015 |
EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers 2 1.6 Effect of the Merge |
|
| November 20, 2015 |
EX-2.2 3 d48841dex22.htm EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), identified on Schedule A hereto (each, a “Shareholder” and, co |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| November 20, 2015 |
CONSULTANCY AND NON-COMPETITION AGREEMENT EX-10.2 Exhibit 10.2 CONSULTANCY AND NON-COMPETITION AGREEMENT THIS CONSULTANCY AND NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?Me |
|
| November 20, 2015 |
EX-2.1 2 d48841dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers |
|
| November 20, 2015 |
EX-2.2 3 d48841dex22.htm EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), identified on Schedule A hereto (each, a “Shareholder” and, co |
|
| November 20, 2015 |
EX-2.2 Exhibit 2.2 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this ?Agreement?), dated as of November 19, 2015, is entered into by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), and the shareholders of Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), identified on Schedule A hereto (each, a ?Shareholder? and, collectively, the ?Sharehol |
|
| November 20, 2015 |
EX-2.1 2 d48841dex21.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers |
|
| November 20, 2015 |
EX-10.1 Exhibit 10.1 NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this ?Agreement?) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (?Parent?), Liberator Medical Holdings, Inc., a Nevada corporation (the ?Company?), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (?MergerSub?), and Mark Libratore, a |
|
| November 20, 2015 |
EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., FREEDOM MERGERSUB, INC., and LIBERATOR MEDICAL HOLDINGS, INC. Dated as of November 19, 2015 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers 2 1.6 Effect of the Merge |
|
| November 20, 2015 |
EX-10.3 6 d48841dex103.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of November 19, 2015, by and among C. R. Bard, Inc., a New Jersey corporation (“Parent”), Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), Freedom MergerSub, Inc., a Nevada corporation and a wholly-owned subsidiary o |
|
| September 11, 2015 |
Liberator Medical Holdings FORM 8-K CURRENT REPORT (Current Report/Significant Event) Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 11, 2015 |
Liberator Medical Holdings Inc. CEO's Address: Exhibit 99.1 CEO's Address Liberator Medical Holdings Inc. CEO's Address: Thank you all for attending and now that we have concluded the formal business of the meeting, I would like to give you a short report on the Company's operations. On behalf of my colleagues on the executive team and the board of directors I would like to welcome you all to our offices in Stuart Florida for our 2015 annual m |
|
| August 26, 2015 |
Exhibit 99.1 Press Release Liberator Medical Declares Cash Dividend of $0.0325 per Share This Is the 11th Consecutive Quarterly Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on September 25, 2015 STUART, FL - (Marketwired) - 08/25/15 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced that on August 25, 2015, its Board of Directors approved a ca |
|
| August 26, 2015 |
Liberator Medical Holdings FORM 8-K CURRENT REPORT (Current Report/Significant Event) Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 11, 2015 |
Liberator Medical Holdings FORM 8-K CURRENT REPORT (Current Report/Significant Event) Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 11, 2015 |
Liberator Medical Holdings DEFINITIVE 14A PROXY STATEMENT Definitive 14A Proxy Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 11, 2015 |
EX-99.1 2 f8k081115ex99z1.htm EXHIBIT 99.1 PRESS RELEASE Liberator Medical Reports Revenue of $20.4 Million and Net Income of $1.7 Million, or $0.03 per Share, for the Three Months Ended June 30, 2015 The Company Reports Revenue Growth of 9.7% for the Three Months Ended June 30, 2015, Compared to the Same Period in 2014 STUART, FL - (Marketwired) - 08/10/15 - Liberator Medical Holdings, Inc. (NYSE |
|
| June 1, 2015 |
Liberator Medical Holdings FORM 8-K CURRENT REPORT (Current Report/Significant Event) Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 1, 2015 |
Liberator Medical Declares Cash Dividend of $0.0325 per Share Exhibit 99.1 Press Release Liberator Medical Declares Cash Dividend of $0.0325 per Share This is the 10th Consecutive Quarterly Cash Dividend and is to be Paid to Shareholders of Record at the Close of Business on June 26, 2015 STUART, FL - (Marketwired) - 05/29/15 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced that on May 29, 2015, its Board of Directors approved a cash divid |
|
| May 12, 2015 |
Exhibit 99.1 Press Release Liberator Medical Reports Revenue of $19.7 Million and Net Income of $1.7 Million, or $0.03 per Share, for the 3 Months Ended March 31, 2015 The Company Reports Revenue Growth of 11.7% for the Three Months Ended March 31, 2015, Compared to the Same Period in 2014 STUART, FL - (Marketwired) - 05/11/15 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced the |
|
| May 12, 2015 |
Liberator Medical Holdings FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2015 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-026729 (State or other jurisdiction (Commission (IRS |
|
| February 25, 2015 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 10) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 8 |
|
| February 24, 2015 |
Liberator Medical Declares Cash Dividend of $0.0325 per Share Exhibit 99.1 Press Release Liberator Medical Declares Cash Dividend of $0.0325 per Share This Is the 9th Consecutive Quarterly Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on March 26, 2015 STUART, FL - (Marketwired) - 02/24/15 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced that on February 23, 2015, its Board of Directors approved a cash |
|
| February 24, 2015 |
Current Report on Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 13, 2015 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 84 |
|
| February 11, 2015 |
Results of Operations and Financial Condition FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 11, 2015 |
Three Months Ended December 31 Exhibit 99.1 Press Release EXHIBIT 99.1 Liberator Medical Reports Record Revenue of $20.2 Million for Its Fiscal First Quarter Ended December 31, 2014 The Company Reports Net Income of $2.4 Million, or $0.05 per Share, for the 3 Months Ended December 31, 2014 Up 14.2% Compared to the Same Period Last Year STUART, FL - (Marketwired) - 02/09/15 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) tod |
|
| January 12, 2015 |
Exhibit 99.1 Presentation Materials EXHIBIT 99.1 |
|
| January 12, 2015 |
FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 16, 2014 |
Results of Operations and Financial Condition FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 16, 2014 |
Exhibit 99.1 Press Release EXHIBIT 99.1 Press Release Source: Liberator Medical Holdings, Inc. Liberator Medical Reports Revenue of $74.5 Million for its Fiscal Year Ended September 30, 2014 Monday, December 15, 8:00 am ET The Company Reports Net Income of $7.8 Million, or $0.15 per share, for the Year STUART, Fla., December 15, 2014 (MARKETWIRED) - Liberator Medical Holdings, Inc. (NYSE MKT:LBMH |
|
| November 24, 2014 |
Liberator Medical Declares Cash Dividend of $0.0325 per Share EX-99.1 2 f8k112414ex99z1.htm EXHIBIT 99.1 PRESS RELEASE EXHIBIT 99.1 Liberator Medical Declares Cash Dividend of $0.0325 per Share This Is the 8th Consecutive Quarterly Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on December 26, 2014 STUART, FL - (Marketwired) - 11/24/14 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced that on November 21, |
|
| November 24, 2014 |
FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 3, 2014 |
Liberator Medical Holdings, Inc. Appoints Two New Members to Board of Directors Exhibit 99.1 Press Release Liberator Medical Holdings, Inc. Appoints Two New Members to Board of Directors Company Expands Number of Board Members From Three to Five STUART, FL - (Marketwired) - 10/31/14 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH)today announced that its Board of Directors has appointed two new members, Ruben Jose King-Shaw, Jr., and Philip M. Sprinkle. The appointments in |
|
| November 3, 2014 |
Current Report on Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 20, 2014 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders Current Report on Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 20, 2014 |
Exhibit 99.1 Remarks of President Exhibit 99.1 Remarks of President and Chief Executive at the Company’s Annual Stockholders Meeting on October 20, 2014 As I begin to speak about Liberator I must remind you that today's comments may contain forward-looking statements and refer those present to the language regarding forward-looking statements in our SEC reports and press releases. In addition, any |
|
| September 22, 2014 |
LBMH / Liberator Medical Holdings, Inc. DEF 14A - - DEFINITIVE 14A PROXY STATEMENT DEF 14A 1 def14a092214def14a.htm DEFINITIVE 14A PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X . Filed by a Party other than the Registrant . Check the appropriate box: . Preliminary Proxy Statement . Confidential, for Use of the Commissio |
|
| August 21, 2014 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 20, 2014 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other jurisdiction of incor |
|
| August 21, 2014 |
Liberator Medical Declares Cash Dividend of $0.0325 per Share, an Increase of $0.0025 or 8.3% Converted by EDGARwiz EXHIBIT 99.1 Liberator Medical Declares Cash Dividend of $0.0325 per Share, an Increase of $0.0025 or 8.3% This Is the 7th Consecutive Quarterly Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on September 26, 2014 STUART, FL - (Marketwired) - 08/20/14 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH)today announced that on August 18, 2014 |
|
| August 18, 2014 |
Results of Operations and Financial Condition Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 14, 2014 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other jurisdiction of incorporat |
|
| August 18, 2014 |
Converted by EDGARwiz EXHIBIT 99.1 Liberator Medical Reports Revenue of $18.6 Million for Its Fiscal Third Quarter Ended June 30, 2014 The Company Reports Net Income of $5.7 Million, or $0.11 per share, for the 9 Months Ended June 30, 2014 up 19.4% Over the Same Period Last Year STUART, FL - (Marketwired) - 08/14/14 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced the financial |
|
| July 1, 2014 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 84 |
|
| June 26, 2014 |
Current Report on Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 26, 2014 |
Exhibit 99.1 Presentation |
|
| June 18, 2014 |
Other Events - FORM 8-K CURRENT REPORT JUNE 18, 2014 Form 8-K Current Report June 18, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 18, 2014 |
Exhibit 99.1 Press Release EXHIBIT 99.1 Liberator Medical Set to Join the Russell Global, Russell 3000 and Russell Microcap Indexes on June 27, According to a Preliminary List Posted on June 13 STUART, FL - (Marketwired) - 06/18/14 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH), a leading provider of direct-to-consumer medical products and supplies, today announced it has been selected to joi |
|
| June 3, 2014 |
8-K 1 f8k0603148k.htm FORM 8-K CURRENT REPORT JUNE 2, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2014 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-026 |
|
| June 3, 2014 |
Liberator Medical Declares Cash Dividend of $0.03 per Share Exhibit 99.1 Press Release EXHIBIT 99.1 Liberator Medical Declares Cash Dividend of $0.03 per Share This Is the 6th Consecutive Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on June 26, 2014 STUART, FL - (Marketwired) - 06/02/14 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced that on May 30, 2014, its Board of Directors approved a cash divid |
|
| May 16, 2014 |
Results of Operations and Financial Condition - CURRENT REPORT ON FORM 8-K Current Report on Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 16, 2014 |
EX-99.1 2 f8k051614ex99z1.htm EXHIBIT 99.1 PRESS RELEASE CORRECTION - Liberator Medical Holdings, Inc. STUART, FL - (Marketwired) - 05/16/14 - In the news release, "Liberator Medical Reports Revenue of $17.6 Million for Its Fiscal Second Quarter Ended March 31, 2014," issued yesterday by Liberator Medical Holdings, Inc. (NYSE MKT: LBMH), we are advised by the company that the financial results men |
|
| February 14, 2014 |
Exhibit 99.1 Press Release Exhibit 99.1 Press Release Source: Liberator Medical Holdings, Inc. Liberator Medical Reports Revenue of $18.6 Million for its Fiscal First Quarter Ended December 31, 2013 Wednesday, February 12, 8:00 am ET The Company Reports Net Income of $2.1 Million, or $0.04 per share, for the Quarter STUART, Fla., February 12, 2014 (NEWSWIRED) - Liberator Medical Holdings, Inc. (NY |
|
| February 14, 2014 |
Results of Operations and Financial Condition 8-K 1 f8k0212148k.htm FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2014 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (St |
|
| February 12, 2014 |
Liberator Medical Holdings FORM 10-Q QUARTERLY REPORT (Quarterly Report) Form 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 4, 2014 |
8-K 1 f8k0204148k.htm CURRENT REPORT ON FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2014 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 ( |
|
| February 4, 2014 |
Liberator Medical Declares Cash Dividend of $0.03 per Share Liberator Medical Declares Cash Dividend of $0.03 per Share STUART, FL - (Marketwired) - 02/03/14 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced that on January 31, 2014, its Board of Directors approved a cash dividend of $0.03 per common share to its shareholders. This is the fifth quarterly cash dividend to be paid by the Company commencing with the dividend paid in May 2013 |
|
| February 3, 2014 |
LBMH / Liberator Medical Holdings, Inc. / Broadfin Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| January 22, 2014 |
Other Events - FORM 8-K CURRENT REPORT FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 22, 2014 |
Liberator Medical Holdings States it Knows of No Events That Could Have Caused Unusual Market Activity STUART, FL - (Marketwired) - 01/21/14 - Liberator Medical Holdings, Inc. |
|
| January 16, 2014 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 84 |
|
| January 13, 2014 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 84 |
|
| December 26, 2013 |
Results of Operations and Financial Condition - FORM 8-K CURRENT REPORT FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 26, 2013 |
EX-99.1 2 f8k122613ex99z1.htm EXHIBIT 99.1 PRESS RELEASE Liberator Medical Reports Revenue of $69 Million for Its Fiscal Year Ended September 30, 2013 The Company Reports Net Income of $7 Million, or $0.14 per Share, for the Year STUART, FL - (Marketwired) - 12/23/13 - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced the financial results for its fiscal year ended September 30, 20 |
|
| November 19, 2013 |
EX-99.1 2 f8k111813ex99z1.htm EXHIBIT 99.1 PRESS RELEASE Liberator Medical Announces That Its Common Stock Has Been Approved for Listing on the NYSE MKT as of November 20, 2013 STUART, FL - (Marketwired) - 11/18/13 - Liberator Medical Holdings, Inc. (OTCBB: LBMH) today announced that its common stock has been approved for listing on the NYSE MKT. The Company expects its common stock to begin tradi |
|
| November 19, 2013 |
8-K 1 f8k1118138k.htm FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2013 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (St |
|
| November 14, 2013 |
Liberator Medical Declares Cash Dividend of $0.03 per Share EX-99.1 2 f8k111413ex99z1.htm EXHIBIT 99.1 PRESS RELEASE Liberator Medical Declares Cash Dividend of $0.03 per Share This Is the 4th Consecutive Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on December 26, 2013 STUART, FL - (Marketwired) - 11/14/13 - Liberator Medical Holdings, Inc. (OTCQB: LBMH) today announced that on November 13, 2013, its Board of Director |
|
| November 14, 2013 |
FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 8, 2013 |
Form 8-A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 87-0267292 (State of incorporation) (IRS Employer Identification Number) 2979 SE Gran Park Wa |
|
| October 31, 2013 |
LBMH / Liberator Medical Holdings, Inc. / KINDERHOOK, LP - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* Liberator Medical Holdings, Inc. Common Stock, par value $0.001 per share 53012L108 Tushar Shah c/o Kinderhook Partners, LLC Two Executive Drive, Suite 585 Fort Lee, NJ 07024 201-461-0955 October 30, 2013 If the filing person has previously filed a sta |
|
| October 28, 2013 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders 8-K 1 f8k1028138k.htm FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2013 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (Sta |
|
| October 28, 2013 |
Exhibit 99.1 Presidents Address EXHIBIT 99.1 President’s Address As I begin to speak about Liberator I must remind you that today’s comments may contain forward-looking statements and refer those present to the language regarding forward-looking statements in our SEC reports and press releases. In addition, any financial results disclosed for fiscal year 2013 are unaudited and subject to adjustmen |
|
| October 16, 2013 |
LBMH / Liberator Medical Holdings, Inc. / MILLENNIUM PARTNERS, L.P. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5) Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53012L108 (CUSIP Number) Simon M. Lorne, Esq. Millennium Management LLC 666 Fifth Avenue, 8th Floor New York, New York 10103 (212) 84 |
|
| September 27, 2013 |
- SCHEDULE 14A DEFINITIVE PROXY STATEMENT Schedule 14A Definitive Proxy Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 3, 2013 |
Liberator Medical Declares Cash Dividend of $0.03 per Share Exhibit 99.1 Press Release Exhibit 99.1 Liberator Medical Declares Cash Dividend of $0.03 per Share This Is the 3rd Consecutive Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on September 26, 2013 STUART, FL - (Marketwired) - 08/30/13 - Liberator Medical Holdings, Inc. (OTCQB: LBMH) today announced that on August 30, 2013, its Board of Directors approved a cash |
|
| September 3, 2013 |
FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 9, 2013 |
Results of Operations and Financial Condition - CURRENT REPORT ON FORM 8-K Current Report on Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 9, 2013 |
EX-99.1 2 f8k080913ex99z1.htm EXHIBIT 99.1 PRESS RELEASE Liberator Medical Reports Revenue of $17.5 Million for Its Third Fiscal Quarter Ended June 30, 2013 The Company Reports Net Income of $2.0 Million, or $0.04 per Share, for the Quarter STUART, FL - (Marketwired) - 08/09/13 - Liberator Medical Holdings, Inc. (OTCQB: LBMH) today announced the financial results for its fiscal third quarter ended |
|
| July 26, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Liberator Medical Holdings, Inc. Common Stock, par value $0.001 per share 53012L108 Tushar Shah c/o Kinderhook Partners, LLC Two Executive Drive, Suite 585 Fort Lee, NJ 07024 201-461-0955 July 26, 2013 If the filing person has previously filed a statem |
|
| July 22, 2013 |
8-K 1 v3505618k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2013 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other ju |
|
| June 17, 2013 |
Liberator Medical Holdings Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 17, 2013 |
Liberator Medical Holdings Exhibit 99.1 Liberator Medical Declares Cash Dividend of $0.03 per Share and Board Authorizes a 1,000,000 Share Buyback Dividend Is to Be Paid to the Shareholders of Record at the Close of Business on July 8, 2013 STUART, FL - (Marketwire) - 06/14/13 - Liberator Medical Holdings, Inc. (OTCQB: LBMH) today announced that on June 13, 2013, its Board of Directors approved a |
|
| June 5, 2013 |
EX-99.1 2 v345446ex99-1.htm PRESS RELEASE Liberator Medical Reports Revenue of $16.7 Million for Its Second Fiscal Quarter Ended March 31, 2013 The Company Reports Net Income of $1.4 Million for the Quarter STUART, FL — (Marketwire) — 05/16/13 — Liberator Medical Holdings, Inc. (OTCBB: LBMH) today announced the financial results for its second fiscal quarter ended March 31, 2013. Sales for the thr |
|
| June 5, 2013 |
Results of Operations and Financial Condition - CURRENT REPORT Liberator Medical Holdings 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 11, 2013 |
LIBERATOR MEDICAL HOLDINGS, INC. 4,862,252 Shares Common Stock 424B3 1 v341202424b3.htm PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(3) Registration No. 333-152652 PROSPECTUS SUPPLEMENT Dated April 11, 2013 LIBERATOR MEDICAL HOLDINGS, INC. 4,862,252 Shares Common Stock This Prospectus relates to 4,862,252 shares of common stock of Liberator Medical Holdings, Inc. (the “Company”), for the sale from time to time by a holder of our securities, or by its p |
|
| April 10, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2013 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other jurisdiction Of incorporation) (Comm |
|
| April 10, 2013 |
LIBERATOR MEDICAL HOLDINGS, INC. Dividend Policy EX-99.1 2 v341054ex99-1.htm DIVIDEND POLICY LIBERATOR MEDICAL HOLDINGS, INC. Dividend Policy We commenced paying a dividend to our shareholders by resolution of our Board of Directors in April 2013. The Company’s policy as established by our Board is to pay a sustainable quarterly dividend to our shareholders. The declaration, amount, and payment of dividends are subject to the determination of ou |
|
| April 8, 2013 |
Liberator Medical Holdings Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 8, 2013 |
Liberator Medical Declares Cash Dividend of $0.02 per Share Liberator Medical Holdings Exhibit 99.1 Liberator Medical Declares Cash Dividend of $0.02 per Share STUART, FL - (Marketwired) - 04/05/13 - Liberator Medical Holdings, Inc. (OTCBB: LBMH) today announced that on April 3, 2013, its Board of Directors approved a cash dividend of $0.02 per common share to its shareholders. This is the first cash dividend paid to shareholders in the Company's history. |
|
| March 22, 2013 |
- POST-EFFECTIVE AMENDMENT TO S-1 Liberator Medical Holdings Form POS AM As filed with the Securities and Exchange Commission on March 22, 2013 Registration No. |
|
| March 22, 2013 |
Liberator Medical Holdings Exhibit 10.2 |
|
| March 22, 2013 |
Liberator Medical Holdings Exhibit 10.2 |
|
| March 22, 2013 |
Liberator Medical Holdings Exhibit 10.16 |
|
| March 22, 2013 |
Liberator Medical Holdings Exhibit 10.16 |
|
| March 22, 2013 |
Liberator Medical Holdings Exhibit 10.2 |
|
| March 22, 2013 |
Liberator Medical Holdings Exhibit 10.2 |
|
| March 22, 2013 |
Liberator Medical Holdings Exhibit 10.16 |
|
| February 14, 2013 |
Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2013 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other jurisdiction (Commission (IRS Emp |
|
| February 14, 2013 |
Liberator Medical Reports Revenue of $17.6 Million for Its First Fiscal Quarter Ended December 31, 2012 The Company Reports Net Income of $1.4 Million for the Quarter STUART, FL - (MARKETWIRE) - 02/14/13 - Liberator Medical Holdings, Inc. (OTCBB: LBMH) today announced the financial results for its first fiscal quarter ended December 31, 2012. Sales for the quarter ended December 31, 2012 increased |
|
| December 26, 2012 |
Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 24, 2012 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other jurisdiction (Commission (IRS Emp |
|
| December 26, 2012 |
Liberator Medical Reports Record Annual Net Revenues of $60.9 Million for Fiscal Year Ended September 30, 2012 The Company Reports Net Income of $2.5 Million for the Year STUART, FL - (MARKETWIRE) - 12/24/12 - Liberator Medical Holdings, Inc. (OTCBB: LBMH) announced net revenues for fiscal year 2012 of $60,943,000, an increase of $8,245,000, or 15.6%, compared with sales of $52,698,000 for fiscal |
|
| October 3, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2012 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other jurisdiction (Commission (IRS Em |
|
| October 3, 2012 |
EX-99.1 2 v325005ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Remarks of President and Chief Executive at the Company’s Annual Stockholders Meeting on September 28, 2012 During fiscal year 2012, we generated double-digit sales growth over the prior year, increased the return on our direct-response advertising campaign compared with last year, and implemented process improvements that allowed us to operate |
|
| August 24, 2012 |
Liberator Medical Holdings DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 15, 2012 |
Results of Operations and Financial Condition, Regulation FD Disclosure - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2012 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other jurisdiction (Commission (IRS Emplo |
|
| August 15, 2012 |
Liberator Medical Reports Net Revenues of $15.0 Million for Third Fiscal Quarter of 2012 Liberator Medical Reports Net Revenues of $15.0 Million for Third Fiscal Quarter of 2012 The Company Reports Net Income of $676,000 for Its Third Fiscal Quarter STUART, Fla., Aug. 15, 2012 (GLOBE NEWSWIRE) - Liberator Medical Holdings, Inc. (OTCBB:LBMH) announced net revenues of $15.0 million for the three months ended June 30, 2012, an increase of $1.7 million, or 12.3%, compared with sales of $1 |
|
| August 15, 2012 |
Company Overview LBMH (OTC) Safe Harbor This presentation contains certain forward - looking statements. |
|
| May 16, 2012 |
EX-99.1 2 v313656ex99-1.htm EXHIBIT 99.1 Liberator Medical Reports Net Revenues of $14.7 Million for Second Fiscal Quarter of 2012 Ended March 31, 2012 The Company Reports Quarter-Over-Quarter Growth of 15.8% STUART, Fla., May 16, 2012 (GLOBE NEWSWIRE) - Liberator Medical Holdings, Inc. (OTCBB:LBMH) announced net revenues of $14,670,000 for the three months ended March 31, 2012, an increase of $2, |
|
| May 16, 2012 |
Results of Operations and Financial Condition - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2012 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other jurisdiction (Commission (IRS Employer |
|
| April 2, 2012 |
LIBERATOR MEDICAL HOLDINGS, INC. 4,862,252 Shares Common Stock 424(b)(3) Filed Pursuant to Rule 424(b)(3) Registration No. 333-152652 PROSPECTUS SUPPLEMENT April 2, 2012 LIBERATOR MEDICAL HOLDINGS, INC. 4,862,252 Shares Common Stock This Prospectus relates to 4,862,252 shares of common stock of Liberator Medical Holdings, Inc. (the “Company”), for the sale from time to time by a holder of our securities, or by its pledgees, assignees and other successors-in-i |
|
| March 14, 2012 |
As filed with the Securities and Exchange Commission on March 14, 2012 Registration No. |
|
| February 17, 2012 |
EX-10.1 2 v303102ex10-1.htm EXHIBIT 10.1 |
|
| February 17, 2012 |
EX-10.1 2 v303102ex10-1.htm EXHIBIT 10.1 |
|
| February 17, 2012 |
EX-10.1 2 v303102ex10-1.htm EXHIBIT 10.1 |
|
| February 17, 2012 |
EX-10.1 2 v303102ex10-1.htm EXHIBIT 10.1 |
|
| February 17, 2012 |
Liberator Medical Holdings Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 15, 2012 |
Liberator Medical Reports Net Revenues of $14.8 Million Exhibit 99.1 Liberator Medical Reports Net Revenues of $14.8 Million STUART, Fla., Feb. 15, 2012 (GLOBE NEWSWIRE) - Liberator Medical Holdings, Inc. (OTCBB:LBMH) today announced first fiscal quarter net revenues of $14.8 million, an increase of $2.6 million, or 21.1%, compared with the first fiscal quarter of 2011. Gross profit for the first fiscal quarter, which ended December 31, 2011, increased |
|
| February 15, 2012 |
Results of Operations and Financial Condition - CURRENT REPORT Liberator Medical Holdings Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Liberator Medical Holdings, Inc. Common Stock, par value $0.001 per share 53012L108 Tushar Shah c/o Kinderhook Capital Management, LLC One Executive Drive, Suite 160 Fort Lee, NJ 07024 201-461-0955 October 4, 2010 If the filing person has previously filed |
|
| February 10, 2012 |
EX-10.1 2 v302045ex10-1.htm EXHIBIT 10.1 |
|
| February 10, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT Liberator Medical Holdings Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 10, 2012 |
EX-10.1 2 v302045ex10-1.htm EXHIBIT 10.1 |
|
| February 10, 2012 |
EX-10.1 2 v302045ex10-1.htm EXHIBIT 10.1 |
|
| January 5, 2012 |
Results of Operations and Financial Condition - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2012 LIBERATOR MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) NEVADA 000-05663 87-0267292 (State or other jurisdiction (Commission (IRS Emplo |
|
| January 5, 2012 |
Liberator Medical Holdings, Inc. and Subsidiaries EX-99.1 2 v244729ex99-1.htm EXHIBIT 99.1 Liberator Medical Reports Record Annual Net Revenues of $52.7 Million for Fiscal Year Ended September 30, 2011 STUART, Fla., Jan. 5, 2012 (GLOBE NEWSWIRE) - Liberator Medical Holdings, Inc. (OTCBB:LBMH) announced record net revenues of $52.7 million for the fiscal year ended September 30, 2011, an increase of $11.8 million, or 28.8%, compared with fiscal ye |
